Patents by Inventor Connor Dobson

Connor Dobson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12631622
    Abstract: Compositions of retroviruses and methods of using the same for gene delivery are disclosed, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Grant
    Filed: October 6, 2025
    Date of Patent: May 19, 2026
    Assignee: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Patent number: 12631621
    Abstract: Compositions of retroviruses and methods of using the same for gene delivery are disclosed, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Grant
    Filed: October 6, 2025
    Date of Patent: May 19, 2026
    Assignee: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Publication number: 20260029398
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: October 6, 2025
    Publication date: January 29, 2026
    Applicant: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Publication number: 20260029399
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: October 6, 2025
    Publication date: January 29, 2026
    Applicant: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Patent number: 12455280
    Abstract: Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Grant
    Filed: January 9, 2025
    Date of Patent: October 28, 2025
    Assignee: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Publication number: 20250249766
    Abstract: An adapter for EV supply equipment (EVSE). The EVSE can have an EVSE connector for charging a PEV. The EVSE connector provides a first connector corresponding to a first charging protocol. The adapter can include a body, a first coupling disposed on the body and configured to engage the first connector, a second coupling disposed on the body and corresponding to a second charging protocol, the body converting the first charging protocol to the second charging protocol, and a lock configured to maintain the body in a locked configuration to the EVSE connector or to the EVSE while allowing the adapter to switch between being locked to the EVSE connector or to the EVSE.
    Type: Application
    Filed: April 20, 2023
    Publication date: August 7, 2025
    Inventors: Mark Westfall, Connor Dobson, Ju Hyun Song, David Klawon, Abdullah Yeaser, Martin Sukup, Andrew David Baglino
  • Publication number: 20250147007
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: January 9, 2025
    Publication date: May 8, 2025
    Applicant: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Patent number: 12222347
    Abstract: Compositions of retroviruses and methods of using the same for gene delivery are disclosed, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Grant
    Filed: August 30, 2023
    Date of Patent: February 11, 2025
    Assignee: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Patent number: 12061188
    Abstract: Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Grant
    Filed: August 30, 2023
    Date of Patent: August 13, 2024
    Assignee: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Patent number: 12061187
    Abstract: Compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: August 13, 2024
    Assignee: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Publication number: 20240230627
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: August 30, 2023
    Publication date: July 11, 2024
    Applicant: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Publication number: 20240044873
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: August 30, 2023
    Publication date: February 8, 2024
    Applicant: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson
  • Publication number: 20220340876
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery to a hematopoietic stem cell (HSC), wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: April 16, 2022
    Publication date: October 27, 2022
    Applicants: Massachusetts Institute of Technology, The Regents of the University of California
    Inventors: Michael Birnbaum, Connor Dobson, Stephanie Gaglione, Kole Roybal, Cassandra Burnett
  • Publication number: 20200371088
    Abstract: Disclosed herein are compositions of retroviruses and methods of using the same for gene delivery, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
    Type: Application
    Filed: March 23, 2020
    Publication date: November 26, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Michael Birnbaum, Connor Dobson